Área de Pediatria, Unidade de Pediatria Médica, Hospital Dona Estefânia, Unidade Local de Saúde São José, Centro Académico de Lisboa, 5.1, Lisbon, Portugal.
Eur J Pediatr. 2024 Nov 29;184(1):51. doi: 10.1007/s00431-024-05892-x.
Neonatal hyperbilirubinaemia is more common in Asian-descendent populations, but differences in disease severity are poorly reported. Our study aimed to compare neonatal hyperbilirubinaemia severity between European and Indian subcontinent descendent newborns. We conducted a single-centre retrospective cohort study including newborns admitted with unconjugated hyperbilirubinaemia (January 2016 to December 2021). Patients were followed during admission, comparing those with European ancestry (control group) and Indian subcontinent ancestry (India, Pakistan, Bangladesh and Nepal) (study group). The primary outcome was severe hyperbilirubinemia (TSB > 25 mg/dL, phototherapy > 6 h or need for exchange transfusion [ET]), and the secondary was TSB levels. Adjusted analysis for potential confounding factors was performed using binary logistic regression models. Of 110 newborns included, 27 (24.5%) had Indian subcontinent ancestry. Occurrence of TSB > 25 mg/dL was significantly higher in the study group (22.2% vs. 4.8%, p = 0.006), while no differences were noted in exposure to phototherapy > 6 h and ET therapy. Logistic regression models for confounding factors adjustment showed Indian subcontinent ancestry as an independent risk factor for TSB > 25 mg/dL (OR 7.49, CI 95% [1.23-45.50]). The study group revealed also higher absolute values of TSB both at admission (22.0 mg/dL vs. 19.6 mg/dL, p = 0.013) and at discharge (13.6 mg/dL vs. 11.4 mg/dL, p = 0.005). Conclusion: Our findings suggest that newborns with Indian subcontinent ancestry might show a higher risk for the development of severe hyperbilirubinemia compared to European ancestry newborns. Implementing earlier treatment thresholds in this subset of patients may help prevent severe hyperbilirubinemia. What is Known: • Indian subcontinent descendent populations have high incidence of neonatal hyperbilirubinaemia but data regarding its severity are scarce. What is New: • This article shows that, compared to European descendent newborns, Indian subcontinent descendent newborns might be at higher risk for severe hyperbilirubinaemia.
新生儿高胆红素血症在亚洲裔人群中更为常见,但疾病严重程度的差异报道较少。我们的研究旨在比较欧洲和印度次大陆后裔新生儿的高胆红素血症严重程度。我们进行了一项单中心回顾性队列研究,纳入了因未结合胆红素升高而入院的新生儿(2016 年 1 月至 2021 年 12 月)。对住院期间的患者进行随访,比较具有欧洲血统(对照组)和印度次大陆血统(印度、巴基斯坦、孟加拉国和尼泊尔)的患者(研究组)。主要结局是严重高胆红素血症(TSB>25mg/dL,光疗>6h 或需要换血治疗[ET]),次要结局是 TSB 水平。使用二元逻辑回归模型对潜在混杂因素进行调整分析。在纳入的 110 名新生儿中,有 27 名(24.5%)具有印度次大陆血统。研究组 TSB>25mg/dL 的发生率明显更高(22.2% vs. 4.8%,p=0.006),而光疗>6h 和 ET 治疗的暴露率无差异。调整混杂因素的逻辑回归模型显示,印度次大陆血统是 TSB>25mg/dL 的独立危险因素(OR 7.49,95%CI [1.23-45.50])。研究组入院时(22.0mg/dL vs. 19.6mg/dL,p=0.013)和出院时(13.6mg/dL vs. 11.4mg/dL,p=0.005)的 TSB 绝对值也更高。结论:我们的研究结果表明,与欧洲血统的新生儿相比,具有印度次大陆血统的新生儿可能更易发生严重高胆红素血症。在这部分患者中实施更早的治疗阈值可能有助于预防严重高胆红素血症。已知:• 印度次大陆后裔人群新生儿高胆红素血症发生率高,但有关其严重程度的数据很少。新发现:• 与欧洲后裔新生儿相比,印度次大陆后裔新生儿可能更易发生严重高胆红素血症。